Attorney General Dave Sunday has announced support for the approved sale of genetic testing company 23andMe to a newly formed non-profit, TTAM Research Institute, following the company’s bankruptcy proceedings.
Sunday, along with a coalition of state Attorneys General, initially objected to any sale that could compromise the personal and genetic data of millions of consumers, including Pennsylvanians. The court-approved sale to TTAM, valued at $305 million, addresses key privacy concerns raised by the coalition.
TTAM was founded by 23andMe’s CEO Ann Wojcicki and will operate as a medical research non-profit. The sale includes several consumer protection provisions:
- No DNA data transfer: All consumer data will remain under the current privacy and cybersecurity protections.
- Data control: Users can permanently delete their data, and new policies ensure deletion requests can be verified by regulators.
- Cybersecurity breach relief: Funds from the sale will be used to compensate the 7 million users affected by the company’s 2023 data breach.
- Focus on research: As a non-profit, TTAM will collaborate with public institutions for medical research, using only data from users who consented.
The sale was finalized and approved by the court on June 27, 2025. The Office of Attorney General will continue to monitor the transition to ensure consumer privacy rights are upheld.
Consumers wishing to delete their 23andMe data may still do so through the company’s website. Those impacted by the bankruptcy may file a complaint with the Bureau of Consumer Protection at 1-800-441-2555.
